Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Recruiting
Observational Study
Low Flow, Low Gradient Aortic Stenosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,350 (estimated)
- Sponsor
- University of Salerno · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular:
* risk factors
* gender differences
* comorbidities
* pharmacological treatment
* TAVR procedural characteristi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* LFLG-AS diagnosis according to current European Society of Cardiology guidelines
* Age 18 years or older
* Written informed consent
Exclusion Criteria:
* LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
* LFLG-AS referred for medical treatment or undergoing surg…
Contacts